Quick Ratio
Higher than 98% of Healthcare sector peers
Updated 1078h ago
Sector Performance
98th percentileCRSP
17.92x
Sector Median
1.31x
Sector Avg
2.65x
Deep Analysis
CRISPR Therapeutics' quick ratio of 17.92x means the company holds nearly 18 dollars of highly liquid assets—like cash and receivables—for every dollar of short-term liabilities, indicating exceptional short-term financial flexibility.
This far exceeds the healthcare sector median of 1.46x, placing the firm in the 98th percentile among its peers. No trend data is available: the year-over-year and quarter-over-quarter changes are both marked as N/A, and only a single historical value (17.92x) is provided. Without a trend, the combination of an extremely high ratio with no direction suggests the metric alone cannot confirm improving or deteriorating liquidity, so investors must rely on other disclosures for context. This extremely high quick ratio supports the overall NEUTRAL verdict because, while it signals strong balance-sheet safety, it may also imply inefficient use of cash that could otherwise be deployed for growth—balancing risk and opportunity.
Frequently Asked Questions
What does the Quick Ratio tell investors about CRSP?
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
How is the Quick Ratio calculated?
Quick Ratio is calculated as: (Cash + Receivables) / Current Liabilities.
How does CRSP's Quick Ratio compare to its sector?
CRSP's Quick Ratio of 17.92x compares to a Healthcare sector median of 1.31x, placing it in the 98th percentile.
Who are CRSP's closest peers by Quick Ratio?
The closest Healthcare peers by Quick Ratio include: BIO (1.02x), BAX (1.01x), BSX (1.00x), BMY (0.91x), DGX (0.91x).
The Formula
(Cash + Receivables) / Current Liabilities
Why It Matters
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
Master CRSP's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CRSP research report →CRSP
17.92x
Sector Median
1.31x
Sector Avg
2.65x
How CRSP's Quick Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.